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Topic Relevance by Timeline 
Summary 
● The process of disruptive innovation is a driving force in making healthcare more afforda-
ble and effective. 
● Building resilience through diversification of financial resources, networking, and focusing 
time/effort can help an academic entrepreneur tolerate setbacks and minimize risks. 
● The sleep medicine case study highlights how fast a disruptive innovation can impact 
organizations on a micro and macro level. 
Introduction 
Disruptive innovation, defined as an innovation that creates a new market and network that even-
tually overtake established organizations, has brought about tremendous changes in several 
industries. It is an important facet of healthcare because it can minimize healthcare costs while 
simultaneously improving the quality of care. The convergence of innovation and healthcare 
within an academic (university) setting creates a distinct class of entrepreneur—the academic 
entrepreneur. To be able to make a sustainable impact in the healthcare industry, the academic 
entrepreneur has to learn to be resilient since they may face resistance as they seek to develop new 
technologies that ultimately can lead to disruptive innovation on the organizational and industry 
level as shown in Figure 1. 
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Figure 1. Characteristics That Foster Disruptive Innovation. 
 
 
Disruptive Innovation in Healthcare 
In recent years, we have seen many efforts to transform the healthcare industry, yet performance, 
cost, and reimbursement issues remain problematic for the industry (see the chapter 
“Reimbursement Strategies and CPT Codes for Device Development”). Clearly, the healthcare 
industry is complex and interconnected, thus different stakeholders have to deploy innovative 
methods to alleviate issues that are prohibiting efficiency and care quality. Beyond providers and 
insurers, innovation in clinical and research settings is necessary to drive healthcare reforms for-
ward. In healthcare, disruptive innovation is more specifically defined as the process of making 
changes, whether large or small, radical or incremental, to products, processes, and services that 
result in the introduction of a novel solution for an organization that adds value to the care received 
and contributes to the knowledge store within and across organizations (O’Sullivan and Dooley). 
An innovative idea brings change to the current healthcare landscape by introducing new or 
different roles for people, different workflows or processes, or new tools or modifications to 
existing ones, either through instant or long-term implementation (O’Sullivan and Dooley). By 
creating disruptive innovation, coupled with the resilience to handle the risks and uncertainty that 
comes along with it, an academic entrepreneur can create a positive impact in the ever-changing 
and uncertain healthcare sector. 
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The U.S. healthcare industry, worth $3.3 trillion, represents almost 17.9% of the U.S. economy 
and involves millions of individuals from many disciplines. Different stakeholders, from 
healthcare payers to clinical researchers, are creating disruptive innovations that are transforming 
the United States’ healthcare system. The role of innovation becomes increasingly important as 
demands for lower costs and better patient outcomes increase. In order for a disruptive innovation 
to be successful, it is necessary to create a solution that allows all players to thrive. To achieve 
this, academic entrepreneurs have to integrate their disruptive innovations into the existing models 
of healthcare. In addition, these institutions will have to adjust their care delivery approaches to 
accommodate these changes. For example, new research developments can lead to technologies 
that displace an existing clinical service line that is less pertinent and/or more costly. The resulting 
new clinical services may also reduce or alter an existing revenue stream for the healthcare insti-
tution. An example of disruptive innovation that will be discussed in detail later in the chapter is 
the change in the diagnostic procedures performed at the Sleep Medicine Program at the University 
of Pennsylvania in response to the advent of new portable sleep study technology. 
 
Currently, stakeholders are mostly focused on minimizing costs in healthcare to make it more 
affordable and accessible by streamlining procedures and changing the payment model. While 
these costs can be reduced at several points in the system, the most effective and feasible solutions 
will 1) implement technologies that treat diseases that would have originally required a physicians’ 
involvement, by enabling the procedures to be performed in a less expensive and more efficient 
way; 2) encourage innovative business models within and outside institutions to ease addition of 
value-adding procedures in an organized manner; and 3) establish a network that will allow dif-
ferent stakeholders in the healthcare system to share data and learn from each other (Christensen 
et al.; Hwang and Christensen).  
Resilience as a Core Component of Disruptive Innovation 
To achieve the promises of disruptive innovation, an academic entrepreneur must have not only 
the technical skill set to invent but also the resilience and adaptability to handle the invention. 
Disruptive innovations can be upsetting because they challenge the established norms and systems 
that exist in healthcare. These innovations can disrupt physicians’ practices, hospitals’ service de-
livery models, payers’ payment systems, and more. Clinical innovations can further challenge the 
standards within an organization’s operation and structure. Investments in equipment, technology, 
and staff will have to be reconsidered if practices change. This impact will often cause health 
systems to reconsider and develop new strategic plans to adapt to the internal changes brought 
about by disruptive innovations. Therefore, to foster innovation, an academic entrepreneur has to 
possess the ability to tolerate negativity and failure as well as to gather insights and recover from 
setbacks. This can be accomplished through applying the following three key lessons: 1) diversi-
fication of financial resources, 2) focusing time and effort, and 3) networking. 
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Diversification of financial resources 
Existing/ongoing financial commitments, debt (heavily leveraged organizations), and overreliance 
on a few sources of income can reduce an organization’s ability to tolerate disruption. In a similar 
way, this can apply for an academic entrepreneur if they rely on only one funding agency, or have 
numerous staff. It is, therefore, important to diversify services as well as financial resources to 
enhance tolerance of failure. Recently, academic funding has begun to rely more and more on 
industry support in addition to federal funding sources. For example, a research lab focusing on a 
specific pathway for an oncology treatment could obtain federal funds from the National Institutes 
of Health (NIH) as well as commercial funding from a strategic alliance with a biopharmaceutical 
company. In clinical settings, funding streams can come from multiple insurance payers and from 
a varied range of clinical services. In addition to diversifying financial streams and support, one 
has to plan ahead to avoid a lack of research funding brought about by delays in the federal funding 
approval process. Specifically, the academic entrepreneur will have to take into account the low 
funding rate of new grant applications and obtain funding far in advance since applications for 
federal funding may require a significant amount of time. Since industry partnerships can in some 
cases be approved more quickly than federal grants, these can be useful to create a balanced fund-
ing portfolio for a lab.   
 
Focusing time and effort 
In order to drive a disruptive innovation into the healthcare system, an academic entrepreneur has 
to be able to focus their efforts and yet know when to disengage if necessary. Time is a finite 
resource. To make significant progress, one has to dedicate time and energy into the research pro-
jects they think will provide the most value. Assessment strategies that apply an objective lens are 
crucial in assessing and reviewing a project. An academic entrepreneur will have to compare 
current progress to objective benchmarks, set up an organized structure for external feedback, and 
reassess the project periodically, in order to know when to stay engaged, pivot, or end the project. 
 
Networking 
Networking—forming strategic alliances with individuals, experts, and organizations—can 
provide significant opportunities for an academic entrepreneur’s idea to develop (see the chapter 
“Forming and Maintaining Meaningful Partnerships Between Academic Scientists and 
Corporations”). Fostering a large network of contacts with diverse expertise and complementary 
skills will enable one to gain different perspectives and approaches to their project, as shown in 
Figure 2. To maximize the value of one’s network, it is also important to engage in face-to-face 
conversations with contacts rather than simply communicating online. A useful strategy is to iden-
tify two new potential contacts from each meeting by asking for suggestions on who else would 
be helpful in your network. In the example below, the meeting with Contact 2 led to two new 
contacts, Contacts 5 and 6, and was more productive than the meetings with Contacts 1 and 3. In 
addition, it is crucial to reach out beyond one’s comfort zone and form partnerships with individ-
uals in very diverse areas. It is typical to network primarily within one’s division, or at an academic 
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conference with others in the same discipline. Yet the true potential for innovation is most effec-
tively realized when one can engage with a collaborator in a completely different field. Seeking 
out these opportunities is not easy, but can offer the greatest reward.  
 
Figure 2. Building a Diversified and Branching Network of Alliances. 
 
 
Current State of Disruptive Innovation 
While healthcare has been resistant to changes that may seem disruptive, there are several trends 
indicating that the sector is accelerating the emergence of disruptive innovations in clinical and 
research settings. The main trends are the shifting focus of services, the increase in cross-industry 
collaboration, and increasing tools and financial avenues to support such innovations. 
 
On a larger scale, organizations are focusing more on providing value-based services for specific 
patient populations. The shift toward value-based healthcare opens up opportunities for the 
healthcare industry to use disruptive innovation to push for better outcomes, quality of care, and 
cost measures instead of pure volume (Hwang and Christensen). An example of an initiative that 
is investing in value-based healthcare is the Centers for Medicare and Medicaid Services (CMS)’s 
$100 billion investment over ten years for innovation efforts to use value-based payment models, 
including the Bundled Payments for Care Improvement and the Medicare Shared Savings Program 
(“Bundled Payments for Care Improvement (BPCI) Initiative: General Information”). The market 
pressure from dominant payers enables the entire healthcare industry to focus on optimizing out-
come and values. The move from a fee-for-service to a fee-for-value system will require 
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fundamental changes in the clinical settings. Thus, primary care providers, specialists, and 
hospitals are increasingly considering the end user, prompting a shift of focus to accountability for 
patient outcomes.  
 
Zooming in to a more micro-level view, there is an increasing number of academic and industry 
collaborations through licensing or sponsored research agreements. These alliance partnerships 
between an academic institution and a dominant industry player can tremendously accelerate 
research and development to mature technologies into viable treatments for unmet needs (see the 
chapter “Identifying Unmet Needs: Problems that Need Solutions”). The CAR-T research and de-
velopment alliance between the University of Pennsylvania and Novartis demonstrates this 
symbiotic partnership that accelerated the disruptive innovation of patient-oriented genetic therapy 
in oncology. Alliances foster and encourage more individuals to participate in academic innovation 
and entrepreneurship (see the “Post Alliance and Sponsored Research Agreements” chapter). 
 
In addition, the introduction of programs, tools, and financial programs that support innovation in 
clinical and research settings has significantly eased the cost burden for an institution and/or the 
academic entrepreneurs themselves. The National Science Foundation’s Innovation Corps (I-
Corps) program was created in 2011 and has been adopted by many top universities to offer sci-
entists and engineers an opportunity to translate their research projects to commercialized goods 
or services that can demonstrate economic and societal benefits (see the chapter “I-Corps as a 
Training Tool for New Technology Development”). Utilizing I-Corps, an academic entrepreneur 
can gain insights and skills in entrepreneurship to support their innovations. Lastly, since capital 
is crucial in stimulating technological innovation, the increase in financing options and innovation 
investments makes it easier for academic entrepreneurs to follow through on their novel ideas. 
While previously there were limited options for an academic entrepreneur to finance their ideas 
and innovations as a startup, the number of private investments from angel investors, venture cap-
italists, and large biopharmas in the healthcare industry has increased significantly (see the 
chapters “Angel Investors” and “Seeking Venture Capital Investment”). Additionally, grants from 
the NIH such as the Small Business Innovation Research (SBIR) and Small Business Technology 
Transfer (STTR) grants (see the chapter “SBIR/STTR Grants: Introduction and Overview”) have 
facilitated the funding of studies and clinical trials to accelerate innovative ventures. 
Case Study: Sleep Medicine—Dealing with a Paradigm 
Shift 
While sleep is a fundamental part of our biology, the study of sleep and the field of sleep disorders 
medicine are relatively new. In 1991, the Center for Sleep and Circadian Neurobiology was estab-
lished at the University of Pennsylvania. Over the course of seven years, studies conducted in the 
sleep lab network grew nearly sixfold, and the number of studies increased from 1,000 to 5,500 
per year. While the great majority of these early studies were primarily in-lab (i.e., conducted in 
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the clinic or hospital), home studies were being developed and gradually adopted. New technology 
development, research validation of the technology, and standardization of the home sleep-study 
testing infrastructure, especially for sleep apnea, eventually accelerated. With the creation of port-
able sleep study units, diagnostic costs were reduced by approximately three- to fivefold relative 
to in-lab studies. Although less data was being collected from home sleep studies, results were 
sufficient to diagnose sleep apnea in patients, based on a growing body of research. While stake-
holders knew about the potential disruptive innovation of home sleep studies for years, it always 
seemed on the distant horizon. Unfortunately, the actual transition itself happened within months, 
when insurance payers decided to implement pre-certification procedures for in-lab studies and 
instead to encourage the use of home sleep studies. This had a large impact on the revenue model 
for sleep labs due to the fixed costs for overnight in-lab facilities and the reduction in income. 
Several large sleep lab programs went bankrupt due to their debt load and lack of financing options 
and had to shut down entirely. The Penn Sleep Center was under significant pressure to revise its 
infrastructure.  
 
In order to cope with this disruptive innovation—home sleep studies—the Penn Sleep Center made 
several fundamental changes (Pack). This included developing its capacity for home sleep studies, 
closing costly facilities (since the division had avoided long-term lease contracts, they were able 
to rapidly downsize facilities), and reducing the number of beds for in-lab studies. The size of 
technologist staff was also reduced, which can be a significant downside of disruptive innovation 
for the workforce. To minimize added staff stress, this was done quickly rather than prolonged 
over time. The pre-certification process was centralized, and staff were quickly informed about 
these initiatives. Some sleep technologists were moved into pre-certification to respond to the in-
creased consult demand for home sleep studies. An overview of the change in models is described 
in Table 1 below. These changes to the clinical practice also had downstream consequences to the 
research program, such as the need to adapt to home sleep study data as well as in-lab sleep data. 
 
Table 1. Clinical Models of Diagnosing Sleep Apnea. 
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Conclusion 
As demonstrated by the sleep medicine case study, disruptive innovation is transforming the field 
of healthcare and the ways both academics and providers conceptualize it. A reimagining of 
healthcare is crucial because it allows for an improved system that can provide value-based care 
for patients as well as minimize costs for various stakeholders. Drawing from the different benefits 
of this new approach, the academic entrepreneur should be equipped with the skills and mindsets—
such as the ability to network and manage risks, as well as the financial foresight—to further propel 
these innovations and help them reach fruition. Furthermore, the academic entrepreneur should 
develop resilience and tolerance for failure, as this will allow them to handle disruptive innovation. 
The changing paradigms that are becoming more patient focused create opportunities for academic 
entrepreneurs to move technological approaches into therapy.  
 
Obtaining expert counsel 
To learn more about disruptive innovations and develop the skills to handle them, an academic 
entrepreneur can seek out advice from peers in other divisions who may have experienced disrup-
tive innovation in their workplace. Universities often have affiliated business schools, which may 
have faculty who are experts in the field. Additionally, innovation centers are becoming more 
common in universities, including within affiliated health systems (see the chapter “Resources at 
Academic Entrepreneurship Centers”). These innovation centers may have programs that assist 
and advise academic entrepreneurs in developing their ventures and address any unexpected chal-
lenges that may arise. 
Practical Guides/Worksheets 
A Nine-Point Checklist to Check Your Resilience for Academic Entrepreneurship: How 
Resilient Are You? 
❏ Is your research funding coming from multiple sources? 
❏ Would you be able to take a one-month sick leave and would your team be able to 
continue the research work? 
❏ Do you have a network/contacts in multiple outside departments and/or divisions of the 
health system or other schools within the university or industry? 
❏ From a clinical perspective, does your clinical success rely on several procedures? 
❏ Does your role/job provide you with the flexibility to partner with other academic 
institutions or companies related to your field of research? 
❏ Does your organization/institution allow you to dedicate sufficient time to your 
research/clinical project? 
❏ Are you mentally comfortable shutting down a project that is not meeting the expected 
objectives or benchmarks? 
❏ Can you participate in programs that assist and advise in innovation and 
entrepreneurship? 
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❏ Do you have a good work-life integration that allows you to have sustained engagement 
in your career? 
 
If you can tick off most of these boxes, that is consistent with a relatively high degree of individ-
ual resilience. 
Resources 
1. “What Is Disruptive Innovation?” 
a. This article by Christensen, Raynor, and McDonald, discusses how the term 
disruptive innovation was first coined by Clayton Christensen, based on his 
research in the disk-drive industry. The theory explores a phenomenon in which 
an innovation transforms an existing sector where high costs and complexity are 
valued through increasing simplicity and affordability. The new product or 
service grows and then takes over the industry as the new standard. 
b. Article available at: https://hbr.org/2015/12/what-is-disruptive-innovation 
2. The Innovator’s Dilemma 
a. This book by Christensen is about how innovation occurs in various industries 
and how to embrace this for success. 
3. “5 Ways to Drive Disruptive Innovation in Healthcare” 
a. This article by Kaplan describes how the healthcare industry is in prime condition 
for disruptive innovation. The high costs and complexity of the system give room 
for improvements that can make it more efficient and more affordable. 
b. Article available at: https://www.inc.com/soren-kaplan/5-ways-to-drive-
disruptive-innovation-in-healthcar.html 
4. The Innovator’s Prescription: A Disruptive Solution for Health Care 
a. This book by Christensen and colleagues applies disruptive innovation to health 
care and discusses strategies to improve affordability. 
b. Video summary about the book: 
https://www.youtube.com/watch?v=tmKqt6jf_H0 
5. “Building a Resilient Organizational Culture” 
a. This article by Everly is about how organizational resilience can cultivate 
innovation and manage failure. 
b. Article available at: https://hbr.org/2011/06/building-a-resilient-organizat 
6. One Mission: How Leaders Build a Team of Teams  
a. This book by Fussell, Goodyear, and McChrystal discusses strategies for unifying 
teams, especially those who are isolated and distrustful. 
7. Grit: The Power of Passion and Perseverance 
a. This book by Duckworth explores the hypothesis that what drives success is not 
“genius” but “grit,” which is a combination of passion and long-term 
perseverance. 
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8. Option B: Facing Adversity, Building Resilience, and Finding Joy  
a. This book by Sandberg and Grant gives lessons on resilience that can be applied 
to diverse situations. 
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